Science ❯ Biotechnology

Vaccine Development

mRNA Technology Clinical Trials mRNA Vaccines Infectious Diseases Immunology mRNA Research COVID-19 Vaccines Clinical Research Public Health Research Innovations in Vaccines Virus-Like Particle Technology African Swine Fever Vaccine Antivenoms Nanoparticle Technology Indigenous Vaccines Cervical Cancer Cancer Immunotherapy Adjuvant Research Respiratory Syncytial Virus RSV Vaccines COBRA Method Mycobacterium tuberculosis Innovative Technologies COVID-19 Vaccine Companies DNA-based Vaccines Avian Flu Vaccines

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

Investigators plan Phase III trials to test whether the vaccines directly boost checkpoint therapy outcomes.

Moderna Scraps CMV Vaccine Program After Phase 3 Failure

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

mRNA Allergy Vaccine Prevents Severe Reactions in Mice

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

UF Researchers Develop Universal mRNA Vaccine That Primes Immune System Against Tumors

Universal mRNA Vaccine Eradicates Tumors in Mice and Advances Toward Human Trials

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage